Grindeks product Viprosal B® receives „Russian Pharma Awards”® recognition

Grindeks product Viprosal B® receives „Russian Pharma Awards”® recognition

21/11/2019

On November 14 in Russia’s capital city Moscow the eighth pharmaceutical industry product competition “Russian Pharma Awards”® ceremony was held during which Grindeks product Viprosal B®* was awarded with the 3rd place in product category “Multifunctional pain treatment manufactured from natural ingredients”.

Competition entrees were evaluated by an internet vote – more than 550,000 pharmaceutical professionals in Russia voted for the best pharmaceutical products in 27 categories. Voting took place for one month in a network created for professional medical personnel.

Viprosal B® is a product for muscle and joint pain treatment and has already previously received prestigious professional awards. In the beginning of 2018, JSC Grindeks product received the golden award in the annual Ukrainian competition “Trade Mark 2018” in “Muscle and Joint Pain Treatment” category by public persons vote. Viprosal B® is also highly evaluated in Belarus and Kazakhstan. In 2018 JSC Grindeks product was offered for patients in 17 countries, and sales amount has increased for 15% comparing to the previous year.

*Non-prescription medication. Before using medication consult doctor or pharmacist. Unwarranted use of medicinal products can be harmful for health.

Related posts

ImgNews4

Grindeks celebrates 75-year anniversary

Today on December 21, JSC Grindeks, the leading pharmaceutical manufacturer in the Baltic States celebrates its 75-year anniversary. Over these 75 years, Grindeks has become...
21/12/2021
magnifiercrossmenu